Newsroom

Digital screen with DNA data background. Nucleic acid sequence. Genetic research. 3d illustration.

July 14, 2021

Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies

: Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
August 4, 2020

Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases

: Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases
May 12, 2020

Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases

: Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases

Media Contacts

Kriya Therapeutics, Inc.
[email protected]
833-574-9289